Plasma metabolites as biomarkers for screening and differential diagnosis of lung cancer
Through the research of plasma metabolomics, some significant metabolites were detected among PLC, BPN, and HPG, which have the potential to be the promising biomarkers for lung cancer screening and differential diagnosis.
Authors
- Shugeng Gao (ORCID: https://orcid.org/0000-0003-0947-4926)
- Terry Z. Liu (ORCID: https://orcid.org/0000-0003-1778-4289)
- Yushun Gao (ORCID: https://orcid.org/0000-0002-0609-1869)
- Fengwei Tan (ORCID: https://orcid.org/0000-0002-8210-684X)
- Ling Wang (ORCID: https://orcid.org/0000-0001-5903-8036)
- Qi Xue (ORCID: https://orcid.org/0000-0002-5086-4654)
Institutions
- Chinese Academy of Medical Sciences & Peking Union Medical College (CN)
- National Cancer Center (US)
- Beijing Chuiyangliu Hospital (CN)
Publication Details
- Journal
- Journal of Cardiothoracic Surgery
- Published
- 2025-12-09
- DOI
- https://doi.org/10.1186/s13019-025-03719-w
- Primary Topic
- Metabolomics and Mass Spectrometry Studies
- Type
- article
- Field-Weighted Citation Impact
- 0.00